Clinical significance of αII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury

Jose A. Pineda, Stephen B. Lewis, Alex B. Valadka, Linda Papa, H. Julia Hannay, Shelley C. Heaton, Jason A. Demery, Ming Cheng Liu, Jada M. Aikman, Veronica Akle, Gretchen M. Brophy, Joseph J. Tepas, Kevin K.W. Wang, Claudia S. Robertson, Ronald L. Hayes

Research output: Contribution to journalArticle

135 Scopus citations

Abstract

Following traumatic brain injury (TBI), the cytoskeletal protein α-11-spectrin is proteolyzed by calpain and caspase-3 to signature breakdown products. To determine whether α-II-spectrin proteolysis is a potentially reliable biomarker for TBI in humans, the present study (1) examined levels of spectrin breakdown products (SBDPs) in cerebrospinal fluid (CSF) from adults with severe TBI and (2) examined the relationship between these levels, severity of injury, and clinical outcome. This prospective case control study enrolled 41 patients with severe TBI, defined by a Glasgow Coma Scale (GCS) score of ≤8, who underwent intraventricular intracranial pressure monitoring. Patients without TBI requiring CSF drainage for other medical reasons served as controls. Ventricular CSF was sampled from each patient at 6, 12, 24, 48, 72, 96, and 120 h following TBI and analyzed for SBDPs. Outcome was assessed using the Glasgow Outcome Score (GOS) 6 months after injury. Calpain and caspase-3 mediated SBDP levels in CSF were significantly increased in TBI patients at several time points after injury, compared to control subjects. The time course of calpain mediated SBDP150 and SBDP145 differed from that of caspase-3 mediated SBDP120 during the post-injury period examined. Mean SBDP densitometry values measured early after injury correlated with severity of injury, computed tomography (CT) scan findings, and outcome at 6 months post-injury. Taken together, these results support that α-II-spectrin breakdown products are potentially useful biomarker of severe TBI in humans. Our data further suggests that both necrotic/oncotic and apoptotic cell death mechanisms are activated in humans following severe TBI, but with a different time course after injury.

Original languageEnglish
Pages (from-to)354-366
Number of pages13
JournalJournal of neurotrauma
Volume24
Issue number2
DOIs
StatePublished - Feb 1 2007

Keywords

  • Biomarker
  • CSF
  • Spectrin
  • Traumatic brain injury

Fingerprint Dive into the research topics of 'Clinical significance of αII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury'. Together they form a unique fingerprint.

  • Cite this

    Pineda, J. A., Lewis, S. B., Valadka, A. B., Papa, L., Hannay, H. J., Heaton, S. C., Demery, J. A., Liu, M. C., Aikman, J. M., Akle, V., Brophy, G. M., Tepas, J. J., Wang, K. K. W., Robertson, C. S., & Hayes, R. L. (2007). Clinical significance of αII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. Journal of neurotrauma, 24(2), 354-366. https://doi.org/10.1089/neu.2006.003789